Free Trial

MorphoSys (MOR) SEC Filings & 10K Form

$18.39
+0.03 (+0.16%)
(As of 05/31/2024 ET)

Recent MorphoSys SEC Filings

DateFilerForm TypeView
05/31/2024
9:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
9:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
9:16 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
9:13 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
1:19 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
05/23/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
8:04 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/17/2024
9:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
3:43 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
05/16/2024
3:31 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/16/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
9:09 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
9:27 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2024
9:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2024
9:31 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2024
9:08 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
3:45 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/07/2024
9:24 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/06/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/03/2024
9:29 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2024
3:31 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/02/2024
9:43 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
7:57 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
3:15 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
9:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/25/2024
9:38 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
10:03 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2024
9:14 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
9:32 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
9:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
3:31 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/18/2024
1:33 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC 13D
04/18/2024
9:13 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2024
3:49 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
04/17/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/16/2024
4:07 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)

In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.

You just have to make this simple move before July 30, 2024.
04/16/2024
9:12 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2024
2:44 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/12/2024
9:54 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
10:57 AM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9
04/11/2024
5:01 AM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T
04/09/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
9:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
9:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2024
9:08 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2024
12:16 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2024
10:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2024
10:37 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
10:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
5:47 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2024
10:27 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
3:12 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
10:13 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2024
10:10 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2024
10:23 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/15/2024
3:46 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
03/15/2024
10:18 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2024
3:52 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
03/14/2024
10:10 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2024
7:27 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2024
4:22 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
03/13/2024
3:07 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/13/2024
3:08 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2024
3:12 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2024
10:12 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
3:36 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 13G
03/11/2024
10:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
6:05 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/08/2024
2:58 PM
Kynam Capital Management, LP (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 13G/A
03/08/2024
9:06 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
9:09 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
11:33 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2024
9:09 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2024
9:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2024
9:29 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/29/2024
9:24 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2024
9:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2024
9:24 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/23/2024
9:37 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2024
9:24 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
9:29 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
5:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/16/2024
10:31 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2024
9:31 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
11:47 AM
Kynam Capital Management, LP (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 13G
Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)

In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.

You just have to make this simple move before July 30, 2024.
02/14/2024
9:42 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2024
9:08 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2024
9:29 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/09/2024
9:21 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/08/2024
9:18 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2024
4:19 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
02/07/2024
9:12 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2024
5:57 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2024
3:58 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MOR) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners